Skip to Content
Merck
CN

B4638

Betahistine dihydrochloride

≥98%

Synonym(s):

Methyl[2-(2-pyridyl)ethyl]amine dihydrochloride

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C8H12N2 · 2HCl
CAS Number:
Molecular Weight:
209.12
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
226-966-5
MDL number:
Assay:
≥98%
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

assay

≥98%

form

powder

SMILES string

Cl.CNCCc1ccccn1

InChI

1S/C8H12N2.2ClH/c1-9-7-5-8-4-2-3-6-10-8;;/h2-4,6,9H,5,7H2,1H3;2*1H

InChI key

XVDFMHARQUBJRE-UHFFFAOYSA-N

Gene Information

Looking for similar products? Visit Product Comparison Guide

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Franziska Lezius et al.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 268(8), 1237-1240 (2011-06-01)
The objective of this study was to evaluate the clinical benefit and the side effects of high dosages of betahistine dihydrochloride (288-480 mg/day) in patients with severe Menière's disease (MD). In this case series 11 patients with MD who had
Christine Adrion et al.
BMC medical research methodology, 12, 137-137 (2012-09-12)
A statistical analysis plan (SAP) is a critical link between how a clinical trial is conducted and the clinical study report. To secure objective study results, regulatory bodies expect that the SAP will meet requirements in pre-specifying inferential analyses and
[Efficacy of vestibo in the treatment of vertebrobasilar insufficiency].
E I Chukanova et al.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 112(4), 53-56 (2012-07-20)
Maurício Malavasi Ganança et al.
Brazilian journal of otorhinolaryngology, 77(4), 499-503 (2011-08-24)
Betahistine is a medicine used to treat vestibular disorders that has also been used to treat tinnitus. To assess the effects of betahistine on tinnitus in patients with vestibular disorders. Retrospective data were collected from patient records for individuals presenting
T Y Kew et al.
The Journal of laryngology and otology, 126(1), 66-71 (2011-08-27)
We report an extremely rare case of duplication of the internal auditory canal associated with dysfunction of both the facial and vestibulocochlear nerves. We also review the literature regarding the integrity of the facial and vestibulocochlear nerves in such cases.

Global Trade Item Number

SKUGTIN
B4638-5G04061833433409

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service